A detailed history of Jackson Creek Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 690 shares of LLY stock, worth $627,437. This represents 0.23% of its overall portfolio holdings.

Number of Shares
690
Previous 755 8.61%
Holding current value
$627,437
Previous $587,000 6.47%
% of portfolio
0.23%
Previous 0.21%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $47,116 - $59,087
-65 Reduced 8.61%
690 $625,000
Q1 2024

May 09, 2024

SELL
$592.2 - $792.28 $26,649 - $35,652
-45 Reduced 5.63%
755 $587,000
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $13,654 - $16,097
-26 Reduced 3.15%
800 $466,000
Q3 2023

Nov 03, 2023

SELL
$434.7 - $599.3 $173,010 - $238,521
-398 Reduced 32.52%
826 $444,000
Q2 2023

Aug 02, 2023

SELL
$350.74 - $468.98 $157,482 - $210,572
-449 Reduced 26.84%
1,224 $574,000
Q4 2022

Feb 03, 2023

SELL
$321.55 - $374.67 $125,082 - $145,746
-389 Reduced 18.87%
1,673 $612,000
Q3 2022

Nov 09, 2022

BUY
$296.48 - $337.87 $2,964 - $3,378
10 Added 0.49%
2,062 $667,000
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $2,508 - $2,945
-9 Reduced 0.44%
2,052 $677,000
Q1 2022

May 03, 2022

SELL
$234.69 - $291.66 $17,836 - $22,166
-76 Reduced 3.56%
2,061 $590,000
Q4 2021

Feb 01, 2022

SELL
$224.85 - $279.04 $2,923 - $3,627
-13 Reduced 0.6%
2,137 $590,000
Q3 2021

Nov 02, 2021

SELL
$221.6 - $272.71 $12,409 - $15,271
-56 Reduced 2.54%
2,150 $497,000
Q2 2021

Aug 03, 2021

SELL
$180.55 - $233.54 $180 - $233
-1 Reduced 0.05%
2,206 $506,000
Q1 2021

May 27, 2021

BUY
$164.32 - $212.72 $16,432 - $21,272
100 Added 4.75%
2,207 $412,000
Q4 2020

Feb 03, 2021

SELL
$130.46 - $172.63 $652 - $863
-5 Reduced 0.24%
2,107 $356,000
Q3 2020

Nov 09, 2020

BUY
$146.22 - $169.13 $308,816 - $357,202
2,112 New
2,112 $313,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.